Corrigendum to "Precision meets repurposing: Innovative approaches in human papillomavirus and Epstein-Barr virus-driven cancer therapy" [Cancer Lett. 607 (2024) 217318]
Cancer Lett. 2025 Feb 1:610:217358.
doi: 10.1016/j.canlet.2024.217358.
Epub 2024 Nov 30.
1 Translational Cancer Research Facility, National Centre for Cancer Care and Research, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar; College of Medicine, Qatar University, P.O. Box 2713, Doha, Qatar. Electronic address: v-QFernandes@hamad.qa.